The joint program of Fox Chase Cancer Center and Temple University Hospital earned accreditation by the Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation.
President Trump’s nominee for NIH director extolled the importance of transparency—just days after HHS rescinded a Nixon-era policy intended to enhance it.
